Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.

@article{Papay2011FactorsIT,
  title={Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.},
  author={Pavol Papay and Alexander Eser and Stefan Winkler and Sophie Frantal and C Primas and Wolfgang Pf Miehsler and Gottfried Novacek and Harald Vogelsang and Clemens Dejaco and Walter Reinisch},
  journal={Inflammatory bowel diseases},
  year={2011},
  volume={17 1},
  pages={
          84-90
        }
}
BACKGROUND Screening for latent tuberculosis (LTB) including chest x-ray, tuberculin skin test (TST), and facultative whole blood interferon-γ assay (IGRA) is part of routine management in inflammatory bowel disease (IBD) patients before starting therapy with tumor necrosis factor (TNF)-α inhibitors. However, in patients with immunomodulators (IM) TST and IGRA might show limitations. METHODS We aimed to evaluate the results from an IGRA (QuantiFERON-TB Gold in Tube) and TST as well as their… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease

  • Digestive Diseases and Sciences
  • 2018
VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

  • The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
  • 2018
VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Similar Papers

Loading similar papers…